3,0
8. Aug. 2024
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Strong community brand, portfolio diversity. Pharma, Crop science, Consumer.
Kontras
Company facing significant headwinds as a result of lack of innovation and operational investment. Impacting culture and retention of IP.